LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Jan 19, 2018
Clinical News
FDA approves AZ's Lynparza for breast cancer
Read More
BioCentury
|
Jan 12, 2018
Company News
FDA approves AZ's PARP inhibitor for breast cancer
Read More
BioCentury
|
Jul 25, 2017
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Jun 17, 2017
Product Development
I-SPY adapts
Veliparib data provide lessons on combos in platform trials like I-SPY-2
Read More
BioCentury
|
Jun 5, 2017
Clinical News
Latest data show Lynparza's survival benefit in breast cancer
Read More
BioCentury
|
May 18, 2017
Clinical News
Keytruda graduates from I-SPY 2
Read More
BioCentury
|
Apr 21, 2017
Clinical News
Veliparib: Ph III data
Read More
BioCentury
|
Apr 21, 2017
Clinical News
Veliparib: Ph III data
Read More
BioCentury
|
Apr 19, 2017
Clinical News
AbbVie's PARP fails in Phase III NSCLC, TNBC trials
Read More
BioCentury
|
Feb 17, 2017
Clinical News
Lynparza shows PFS benefit in Phase III breast cancer study
Read More
Items per page:
10
1 - 10 of 44
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help